# RASSF1

## Overview
RASSF1 (Ras association domain family member 1) is a gene that encodes a protein involved in various cellular processes, primarily functioning as a tumor suppressor. The protein, Ras association domain family member 1, is characterized by its Ras association (RA) domain and Salvador-RASSF-Hippo (SARAH) domain, which facilitate interactions with Ras GTPases and other proteins, respectively (Richter2009The; Volodko2014RASSF). It is expressed in multiple isoforms, with RASSF1A being the most extensively studied due to its significant role in regulating cell cycle progression, apoptosis, and microtubule stability (Donninger2016Ras; van2007The). The RASSF1A isoform is frequently inactivated in various cancers through promoter hypermethylation, highlighting its clinical significance as a potential biomarker for cancer diagnosis and prognosis (dammann2003epigenetic; van2007The).

## Structure
The RASSF1 protein is characterized by several key structural domains that contribute to its function as a tumor suppressor. It contains a Ras association (RA) domain, which is involved in interactions with Ras GTPases, and a Salvador-RASSF-Hippo (SARAH) domain, which facilitates protein-protein interactions and dimerization (Richter2009The; Volodko2014RASSF). The RA domain is located towards the C-terminus in isoforms such as RASSF1A and RASSF1C, and it plays a crucial role in binding to active Ras proteins (van2007The; Donninger2007The).

RASSF1A also contains a cysteine-rich diacylglycerol/phorbol ester-binding domain (C1 domain) at the N-terminus, which is involved in microtubule association and stabilization (Richter2009The; Liu2003Control). This domain is essential for its interaction with microtubules and is implicated in cell cycle regulation (Richter2009The).

The protein undergoes post-translational modifications, including phosphorylation by Aurora-A kinase, which affects its interaction with microtubules and its ability to induce cell cycle arrest (Richter2009The). RASSF1 is expressed in multiple isoforms due to alternative splicing, with RASSF1A and RASSF1C being the most studied. These isoforms share common domains but have distinct N-terminal regions, contributing to their unique functional roles (Donninger2016Ras; van2007The).

## Function
The RASSF1 gene, particularly its RASSF1A isoform, functions as a tumor suppressor in healthy human cells by regulating cell cycle progression, apoptosis, and microtubule stability. RASSF1A induces cell cycle arrest by engaging the retinoblastoma (Rb) family cell cycle checkpoint and inhibiting cyclin D1 accumulation, which is crucial for the G1/S-phase transition (Shivakumar2002The; van2007The). It interacts with p120 E4F to enhance G1 cell cycle arrest and regulates mitotic progression by interacting with Cdc20, preventing the degradation of mitotic cyclins and delaying mitotic progression beyond metaphase (van2007The; Donninger2007The).

RASSF1A also plays a role in apoptosis by interacting with pro-apoptotic kinases such as MST1 and MST2, and forming complexes with proteins like MOAP1, which are involved in apoptotic pathways (Donninger2007The). It stabilizes microtubules by binding to them, which is essential for proper mitotic spindle dynamics and cell cycle progression (Liu2003Control; Arnette2014Microtubule). This stabilization is crucial for maintaining genomic stability and preventing tumorigenesis (Liu2003Control). RASSF1A's interaction with microtubule-associated proteins further supports its role in modulating microtubule dynamics and stability (Dallol2004RASSF1A).

## Clinical Significance
The RASSF1 gene, particularly its RASSF1A isoform, is frequently inactivated in various cancers through promoter hypermethylation, a common epigenetic alteration that leads to its silencing. This inactivation is observed in numerous cancer types, including lung, breast, prostate, and thyroid cancers, and is associated with poor prognosis and advanced tumor stages (dammann2003epigenetic; van2007The). The loss of RASSF1A expression disrupts its tumor suppressor functions, contributing to carcinogenesis by allowing unchecked Ras activity, which promotes tumor growth (dammann2003epigenetic).

RASSF1A's silencing is often linked to increased inflammation and tumorigenesis, as it plays a role in several signaling pathways, including the TGF-β1/SMADS/AMPK/NF-κB and Hippo pathways. Its deficiency can lead to enhanced inflammation and malignant transformation of cells (Li2020Signaling). The gene's methylation status is considered an early event in tumorigenesis and is being explored as a biomarker for cancer diagnosis and prognosis (van2007The).

Mutations in RASSF1A, although rare, can result in functionally impaired proteins that affect cell cycle arrest and growth suppression, further contributing to tumorigenesis (van2007The).

## Interactions
RASSF1A, a member of the Ras association domain family, interacts with several proteins, playing a crucial role in various cellular processes. It associates with the E1A-regulated transcription factor p120 E4F, enhancing G1 cell cycle arrest and S phase inhibition, and linking RASSF1A to major tumor suppressors like p14ARF, retinoblastoma, and p53 (Fenton2004Identification). RASSF1A also interacts with the kinase Mst1, a key component of the Hippo signaling pathway, through its SARAH domain. This interaction is essential for Mst1-mediated apoptosis, as RASSF1A enhances Mst1 activity in a concentration-dependent manner and promotes apoptosis in response to Fas signaling (Oh2006Role).

RASSF1A is involved in microtubule dynamics by interacting with microtubule-associated proteins such as MAP1B and VCY2IP1/C19ORF5. These interactions stabilize microtubules and protect them from depolymerization, which is crucial for maintaining cellular structure and function (Dallol2004RASSF1A). Additionally, RASSF1A interacts with various RAS family members, including atypical RAS proteins like ERAS and DIRAS3, influencing signaling pathways that regulate cell shape and calcium channel activity (Rezaei2021A). These interactions highlight RASSF1A's multifaceted role in cellular regulation and tumor suppression.


## References


[1. (Arnette2014Microtubule) Christopher Arnette, Nadia Efimova, Xiaodong Zhu, Geoffrey J. Clark, and Irina Kaverina. Microtubule segment stabilization by rassf1a is required for proper microtubule dynamics and golgi integrity. Molecular Biology of the Cell, 25(6):800–810, March 2014. URL: http://dx.doi.org/10.1091/mbc.e13-07-0374, doi:10.1091/mbc.e13-07-0374. This article has 19 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1091/mbc.e13-07-0374)

[2. (Dallol2004RASSF1A) Ashraf Dallol, Angelo Agathanggelou, Sarah L. Fenton, Jalal Ahmed-Choudhury, Luke Hesson, Michele D. Vos, Geoffrey J. Clark, Julian Downward, Eamonn R. Maher, and Farida Latif. Rassf1a interacts with microtubule-associated proteins and modulates microtubule dynamics. Cancer Research, 64(12):4112–4116, June 2004. URL: http://dx.doi.org/10.1158/0008-5472.can-04-0267, doi:10.1158/0008-5472.can-04-0267. This article has 119 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-04-0267)

[3. (Richter2009The) Antje M. Richter, Gerd P. Pfeifer, and Reinhard H. Dammann. The rassf proteins in cancer; from epigenetic silencing to functional characterization. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1796(2):114–128, December 2009. URL: http://dx.doi.org/10.1016/j.bbcan.2009.03.004, doi:10.1016/j.bbcan.2009.03.004. This article has 70 citations.](https://doi.org/10.1016/j.bbcan.2009.03.004)

4. (dammann2003epigenetic) Reinhard Dammann, U Schagdarsurengin, M Strunnikova, M Rastetter, C Seidel, L Liu, Stefania Tommasi, and GP Pfeifer. Epigenetic inactivation of the ras-association domain family 1 (rassf1a) gene and its function in human carcinogenesis. Histology and histopathology, 2003. This article has 229 citations and is from a peer-reviewed journal.

[5. (Volodko2014RASSF) Natalia Volodko, Marilyn Gordon, Mohamed Salla, Haya Abu Ghazaleh, and Shairaz Baksh. Rassf tumor suppressor gene family: biological functions and regulation. FEBS Letters, 588(16):2671–2684, March 2014. URL: http://dx.doi.org/10.1016/j.febslet.2014.02.041, doi:10.1016/j.febslet.2014.02.041. This article has 96 citations and is from a peer-reviewed journal.](https://doi.org/10.1016/j.febslet.2014.02.041)

[6. (Liu2003Control) Limin Liu, Stella Tommasi, Dong-Hyun Lee, Reinhard Dammann, and Gerd P Pfeifer. Control of microtubule stability by the rassf1a tumor suppressor. Oncogene, 22(50):8125–8136, November 2003. URL: http://dx.doi.org/10.1038/sj.onc.1206984, doi:10.1038/sj.onc.1206984. This article has 160 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1038/sj.onc.1206984)

[7. (Oh2006Role) Hyun Jung Oh, Kyung-Kwon Lee, Su Jung Song, Mi Sun Jin, Min Sup Song, Joo Hyun Lee, Chang Rak Im, Jie-Oh Lee, Shin Yonehara, and Dae-Sik Lim. Role of the tumor suppressor rassf1a in mst1-mediated apoptosis. Cancer Research, 66(5):2562–2569, March 2006. URL: http://dx.doi.org/10.1158/0008-5472.can-05-2951, doi:10.1158/0008-5472.can-05-2951. This article has 155 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-05-2951)

[8. (Rezaei2021A) Soheila Rezaei Adariani, Neda S. Kazemein Jasemi, Farhad Bazgir, Christoph Wittich, Ehsan Amin, Claus A.M. Seidel, Radovan Dvorsky, and Mohammad R. Ahmadian. A comprehensive analysis of ras-effector interactions reveals interaction hotspots and new binding partners. Journal of Biological Chemistry, 296:100626, January 2021. URL: http://dx.doi.org/10.1016/j.jbc.2021.100626, doi:10.1016/j.jbc.2021.100626. This article has 15 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1016/j.jbc.2021.100626)

[9. (Donninger2007The) Howard Donninger, Michele D. Vos, and Geoffrey J. Clark. The rassf1a tumor suppressor. Journal of Cell Science, 120(18):3163–3172, September 2007. URL: http://dx.doi.org/10.1242/jcs.010389, doi:10.1242/jcs.010389. This article has 330 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1242/jcs.010389)

[10. (Donninger2016Ras) Howard Donninger, M. Lee Schmidt, Jessica Mezzanotte, Thibaut Barnoud, and Geoffrey J. Clark. Ras signaling through rassf proteins. Seminars in Cell &amp; Developmental Biology, 58:86–95, October 2016. URL: http://dx.doi.org/10.1016/j.semcdb.2016.06.007, doi:10.1016/j.semcdb.2016.06.007. This article has 78 citations.](https://doi.org/10.1016/j.semcdb.2016.06.007)

[11. (Li2020Signaling) Nanhong Li, Yu Zeng, and Jian Huang. Signaling pathways and clinical application of rassf1a and shox2 in lung cancer. Journal of Cancer Research and Clinical Oncology, 146(6):1379–1393, April 2020. URL: http://dx.doi.org/10.1007/s00432-020-03188-9, doi:10.1007/s00432-020-03188-9. This article has 18 citations and is from a peer-reviewed journal.](https://doi.org/10.1007/s00432-020-03188-9)

[12. (Shivakumar2002The) Latha Shivakumar, John Minna, Toshiyuki Sakamaki, Richard Pestell, and Michael A. White. The rassf1a tumor suppressor blocks cell cycle progression and inhibits cyclin d1 accumulation. Molecular and Cellular Biology, 22(12):4309–4318, June 2002. URL: http://dx.doi.org/10.1128/mcb.22.12.4309-4318.2002, doi:10.1128/mcb.22.12.4309-4318.2002. This article has 293 citations and is from a domain leading peer-reviewed journal.](https://doi.org/10.1128/mcb.22.12.4309-4318.2002)

[13. (Fenton2004Identification) Sarah L. Fenton, Ashraf Dallol, Angelo Agathanggelou, Luke Hesson, Jalal Ahmed-Choudhury, Shairaz Baksh, Claude Sardet, Reinhard Dammann, John D. Minna, Julian Downward, Eamonn R. Maher, and Farida Latif. Identification of the e1a-regulated transcription factor p120e4f as an interacting partner of the rassf1a candidate tumor suppressor gene. Cancer Research, 64(1):102–107, January 2004. URL: http://dx.doi.org/10.1158/0008-5472.can-03-2622, doi:10.1158/0008-5472.can-03-2622. This article has 61 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1158/0008-5472.can-03-2622)

[14. (van2007The) Louise van der Weyden and David J. Adams. The ras-association domain family (rassf) members and their role in human tumourigenesis. Biochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1776(1):58–85, September 2007. URL: http://dx.doi.org/10.1016/j.bbcan.2007.06.003, doi:10.1016/j.bbcan.2007.06.003. This article has 51 citations.](https://doi.org/10.1016/j.bbcan.2007.06.003)